Gene Query: THBS3

Dataset Description Geneva Score
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells (Poly(I:C) and LPS) 36.62
Tumor exosome integrins determine organotropic metastasis 35.5
SMUG1 promotes telomere maintenance through telomerase RNA end-processing 34.67
Transcriptome Sequencing of Adipose-Derived Mesechymal Stromal Cells 33.53
A SIRT1-centered Circuitry Regulates Breast Cancer Stemness and Metastasis 32.7
Estrogen deprivation triggers and immunosuppressive phenotype in breast cancer cells 30.87
Genome wide transcriptome analysis of palbociclib or GSK3326595 treated A375 cells [Palbociclib_GSK_RNASeq] 30.67
Ascorbate Suppresses VEGF Expression in Retinal Pigment Epithelial Cells 26.05
Identification of miR-100 and miR-125b targets by AGO2 RIP-seq and RNA-seq after ectopic expression of miR-100 or miR-125b and evaluation of the TGFb expression signature in PANC-1 cells by RNA-seq 25.78
Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of binding sites in a cell type-specific manner 24.95
Hydrogel scaffolds promote neural gene expression and structural reorganization in human astrocyte cultures 23.99
Waterpipe Smoking Induces Epigenetic Changes in the Small Airway Epithelium [RNA-Seq] 22.81
Waterpipe Smoking Induces Epigenetic Changes in the Small Airway Epithelium 22.81
Integrative vascular endothelial cell genomics identify AIDA as a coronary artery disease candidate gene 22.07
Integrative vascular endothelial cell genomics identify AIDA as a coronary artery disease candidate gene (RNAseq) 22.07
Differential gene expression in Jagged1 treated human dental pulp cells. 21.68
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors [RNA-seq 2] 21.45
Cell-specific expression and function patterns of microRNA-150-5p in liver fibrogenesis 20.58
Self-organization of polarized cerebellar plate neuroepithelium in three-dimensional culture of human pluripotent stem cells 20.12
Genome-wide profiling of siRNA targeting EWS-FLI1 in TC32 Ewing sarcoma cell line 19.74
Identifying lincRNA as prognostic biomarker for clear cell renal cell carcinoma 19.63
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors 19.36
RNA-seq of UGP2 mutant human embryonic stem cells and in vitro differentiated neural stem cells 19.02
Profiling gene expression changes in ovarian cancer cells seeded on 3D organotypic culture of omentum 19.01
Effect of CTCF and Rad21 knockdown on SLK cells and KSHV gene expression 18.92
CASZ1 directly regulates expression of myogenic genes through regional epigenetic modifications to induce muscle and rhabdomyosarcoma cell differentiation 17.41
MYOD Remodeling of the Genome Architecture during Myogenic Conversion of Somatic Cells 17.07
Patient-derived luminal breast cancer xenografts with progestins 17.0
RNAseq analysis of patient-derived luminal breast cancer xenografts treated with progestins 17.0
A Primate lncRNA Mediates Notch Signaling During Neuronal Development by Sequestering miRNA [SHSY5Y cells] 16.87
MYOD Gene Expression Regulation during Myogenic Conversion of Fibroblasts 16.59
Coordinated control of senescence by lncRNA UCA1 and a novel CAPERα/TBX3 co-repressor 16.46
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors 16.24
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 16.24
Improved post thaw function and genetic changes for mesenchymal stromal cells cryopreserved using multicomponent osmolyte solutions 15.82
Enhancer divergence and cis-regulatory evolution in the human and chimpanzee neural crest 15.01
RNA helicase A is necessary for KIF1Bβ tumor suppression in neuroblastoma 14.98
LED, a long non-coding RNA activator of enhancer RNAs, is hypermethylated in human cancers 14.75
The Human Testis Cell Atlas via Single-cell RNA-seq 14.61
Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis [d7+d14] 14.32
transcriptomic profiling of HEK293 cells upon individual knockdown of the splicing factors RBM17, U2SURP or CHERP 14.23
MYCL and EP400 are required for Max and MCPyV mediated gene activation 14.23
NR2F2 study 14.22
Estrogen response in breast cancer cell line MCF-7 is dependent on NR2F2 [RNA-seq] 14.22
Transcriptome profiling of influenza virus-infected human bronchial epithelial cells 14.15
Re-Wiring 3D Nuclear Architecture by a Single Transcription Factor during Somatic Cell Reprogramming 14.14
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer [RNA-Seq] 14.12
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer 14.12
Major roles of cyclobutane pyrimidine dimers, nucleotide excision repair and ATR in the alternative splicing response to UV irradiation 13.95
Whole transcriptome RNA sequencing of human cells after HCV infection (ML-1 thyroid cell line, primary thyrocytes and Huh7.5 hepatocyte cell line) 13.59
Lentiviral CRISPR Epigenome Editing of Inflammatory Receptors as a Gene Therapy Strategy for Disc Degeneration 13.56
FUS KO mRNA sequencing and anti-FUS RNA immunoprecipitation sequencing 13.51
Differential expression of human parthenogenic stem cells, neural stem cells and DA progenitors. 13.35
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice 13.2
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice [RNA-seq] 13.2
ZNF804A transcriptome networks in differentiating human neurons derived from induced pluripotent stem cells 13.1
Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13 13.1
Rapid neurogenesis through transcriptional activation in human stem cell (RNA-Seq) 13.0
Activation of a SOX2-dependent transcriptional regulatory circuit drives glioblastoma. 12.77
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 [RNA-seq] 12.71
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 12.71
Transcriptional Profiling Identifies Novel Regulators of Macrophage Polarization 12.52
Transcriptional Profiling Identifies Novel Regulators of Macrophage Polarization [RNA-Seq] 12.52
Nucleotide excision repair capacity increases during differentiation of human embryonic carcinoma cells into neurons and muscle cells 12.17
Leukodystrophy-associated POLR3A mutations down-regulate the RNA polymerase III transcript and important regulatory RNA BC200 12.14
MDM2 and MDM4 are Therapeutic Vulnerabilities in Malignant Rhabdoid Tumors 11.99
Characterization of sperm lncRNA and its differently expression in the sperm of asthenozoospermic patients 11.83
The Unfolded Protein Response Regulator, ATF6, Promotes Mesodermal Differentiation 11.8
Integrated analyses of early responses to radiation in glioblastoma identify new alterations in RNA processing and candidate targets to improve treatment outcomes 11.79
RNA-sequencing WT vs SOCS3 knockout Glioblastoma stem-cells 11.77
RNA-Seq analysis RPE1 cells following exposure to Nutlin-3 to identify target genes of p53 [tpo12] 11.68
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export II 11.55
Detailed genomic and molecular characterization of Indian induced pluripotent stem cell lines 11.39
Differential gene expression analysis between proliferating and quiescent human dermal fibroblasts 11.36
The histone H3.3K36M mutation reprograms the epigenome of chondroblastomas 11.35
SIRT7 Antagonizes TGF-β Signaling and Inhibits Breast Cancer Metastasis 11.32
Human interleukin-4 treated regulatory macrophages promote epithelial wound healing and reduce colitis in an mouse model 11.28
Transcriptomic profiling of mesenchymal stem cells (MSC) differentiation into mesangial cells 11.12
RNA-seq of healthy CD34+ HSPCs after co-culture with myelodyplastic syndrome patient-derived mesenchymal stromal cells 11.07
Genome-wide expression analysis of young, senescent and p38MAPK-inhibitited senescent human fibroblasts. 10.84
RNA-seq and flow-cytometry of conventional, scalp, and palmoplantar psoriasis reveal shared and distinct molecular pathways 10.65
Single Cell Sequencing Reveals Gene Expression Signatures Associated with Bone Marrow Stromal Cell Subpopulations and Time in Culture [NGS_bulk cell RNA-seq] 10.56
ASCL1 mediates neuronal differentiation of primary GBM stem cell cultures upon Notch signalling blockade [RNA-seq] 10.54
The histone variant H3.3 G34W substitution in giant cell tumor of the bone link chromatin and RNA processing [RNA-seq] 10.53
Human SETMAR is a DNA sequence-specific histone-methylase with a broad effect on the transcriptome 10.43
LINE-1 elements are derepressed in senescent cells and elicit a chronic Type-I Interferon response 10.36
Differentially expressed (DE) genes analysis in synovial fluid mesenchymal stem cells (SF-MSCs), SF-MSC derived iPSCs and iPSC derived MSCs (iPSC-MSCs) 10.34
Parkinson’s Disease Genetic Risk in a Midbrain Neuronal Cell Line 10.3
Profile of gene expression in U87-MG xenografts expressing control vector (V0), the ubiquitin ligase KPC1 or the p50 subunit of the NF-kB transcription factor, using RNASeq analysis of transcripts mapped independently to the human and murine genomes 10.21
Regulation of cellular heterogeneity and rates of symmetric and asymmetric divisions in triple-negative breast cancer 10.18
Effect of SHP2 inhibition on hepatic stellate cell transcriptome. 9.94
Treatment Paradigms for Retinal and Macular Diseases Using 3-D Retina Cultures Derived From Human Reporter Pluripotent Stem Cell Lines 9.73
Transcriptomic analysis of effect of oncolytic measles virus (MV) on transformed and non-transformed bone marrow-derived mesenchymal stem cells (MSCs) 9.67
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies [RNA-Seq] 9.64
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies 9.64
The mSWI/SNF ATPase module mediates subcomplex identity and non-catalytic targeting in SCCOHT [RNA-seq] 9.62
The ATPase module of mammalian SWI/SNF family complexes mediates subcomplex identity and catalytic activity-independent genomic targeting 9.62
Differential gene expression of human melanoma cells [RNA-seq] 9.62
GDF6-induced BMP signaling reawakens a neural crest identity in melanoma to prevent cell death and differentiation 9.62
A Stable Transcription Factor Complex Nucleated by Dimeric AML1-ETO Controls Leukaemogenesis 9.55
Transcriptomic profiling discloses molecular and cellular events related to neuronal differentiation in SH-SY5Y cells 9.52
RNA-seq of human aneuploid cell lines with Trisomy 21 9.51
Progressive motor neuron pathology and the role of astrocytes in a human stem cell model of VCP-related ALS 9.42
Transcriptome sequencing of human coronary artery smooth muscle cell under treatment of nitrated fatty acid 9.18
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference 9.12
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference [RNA-Seq] 9.12
Small molecule targets TMED9, promotes lysosomal degradation to reverse proteinopathy 9.06
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure or Aurora kinase inhibition [tpo3] 8.95
Integrative analysis identifies lincRNAs up- and downstream of neuroblastoma driver genes (ALK) 8.88
Ectoderm specification of H1 human embryonic stem cells 8.5
RNA sequencing analysis of human embryonic stem cells and axial progenitors 8.47
Genome-wide chromatin analysis of Ewing sarcoma 8.47
Genome-wide chromatin analysis of Ewing sarcoma (RNA-seq) 8.47
Spatial proximity to fibroblasts impacts molecular features and therapeutic sensitivity of breast cancer cells influencing clinical outcomes 8.46
Adaptation of the Kinome Promotes Resistance to BET Bromodomain Inhibitors in Ovarian Cancer 8.46
RNA-seq in untreated and flagellin-treated Human Intestinal Myofibroblast cells (HIMF) 8.44
Studying the selectivity of a targeted small molecule degrading a hypoxia-associated non-coding RNA 8.42
Endometrial epithelial cell transcriptome response to co-culture with adipose stromal cells 8.39
RNA expression profiling of human mPB or CB-derived CD34+ cells treated with UM171 at different doses 8.37
Defining a microRNA-mRNA targetome for calcineurin inhibitor induced nephrotoxicity 8.36
TGF-b-activated LncRNA LINC00115 is a critical regulator for glioma stem-like cell tumorigenicity 8.33
Identification of Sin3B regulated genes during quiescence 8.31
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation 8.26
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation [RNA-Seq] 8.26
A peninsular structure coordinates asynchronous differentiation with morphogenesis to generate pancreatic islets [bulk vs buds] 8.24
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 8.23
TT-seq captures simultaneous activation of eRNAs and promoters during T cell activation 8.21
Analysis of transcriptional regulation by Myt1 and Myt1l 8.21
RNA-seq of PC3 prostate cancer cell line xenografts in mice administered the ghrelin receptor antagonist [D-Lys3]-GHRP-6 or PBS for two weeks 8.21
ZRANB2 and SYF2 mediated splicing programs converging on ECT2 are involved in breast cancer cell resistance to doxorubicin 8.21
Role of FGFR1 in neuronal devlopment 8.17
A Novel Population of Human Cardiac Resident Mesenchymal Stem Cells 8.12
Deletion of DXZ4 on the human inactive X chromosome eliminates superdomains and impairs gene silencing 8.07
RNA sequencing analysis of human podocytes reveals glucocorticoid regulated gene networks targeting non-immune pathways 8.02
PHF20 readers link methylation of histone H3K4 and p53 with H4K16 acetylation 7.99
An aspartyl protease defines a novel pathway for export of Toxoplasma proteins into the host cell 7.97
Generation of trichogenic adipose-derived stem cells by expression of three factors 7.95
Unraveling cis-regulatory elements by mapping structural changes in mRNAs 7.94
Combined inhibition of STAT3 and DNA repair in palbociclib-resistant ER-positive breast cancer 7.92
RNA-seq identifies novel lncRNAs involved in vascular smooth muscle cell proliferation 7.9
Spliceosomal disruption of the non-canonical BAF complex in cancer 7.84
RNA-seq characterization of downstream effects of upregulating SMN2 via down-regulating PRC2 or blocking the PRC2:SMN-AS1 interaction with a mixmer oligonucleotide 7.73
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (human cell lines RNA-Seq) 7.7
Chronophin regulates metabolic and transcriptomic features of glioblastoma stem-like cells 7.69
DAOY-NERT2 Notch/Hypoxia Transcriptome Analysis 7.66
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function 7.63
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function [Rnase-Seq] 7.63
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells [RNA-seq] 7.42
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells 7.42
a-synuclein accumulation in an iPSC derived model of early onset sporadic Parkinson’s Disease reveals novel drug targets 7.36
Modeling Familial Cancer with iPSC Approaches 7.36
De novo reconstruction of human adipose reveals conserved lncRNAs as regulators of brown adipogenesis 7.31
Glioblastoma stem cells infected by ZIKA virus 7.3
RNA-seq analysis of A2780 and OVCAR3 human ovarian cancer cell lines after overexpression of collagen type XI alpha 1 (COL11A1) 7.27
Genetic disruption of COX-1 inhibits multiple oncogenic pathways 7.18
Expression data from human perivascular stem cell-derived extracellular vesicles (PSC-EVs) and PSCs 7.14
Transcriptomic analysis of healthy donor and Sickle Cell Disease (SCD) hematopoietic stem/progenitor cells 7.11
RNA expression analysis of neuroblastoma cell lines treated with epigenetic drugs 7.07
Effects of Freeze-Thawing and Intravenous Infusion on Mesenchymal Stromal Cell Gene Expression 7.03
Effect of Toxoplasma gondii efector TgIST on global transcriptome of human foreskin fibroblasts (HFFs) upon type I IFN activation 6.88
Regionally specified human pluripotent stem cell-derived astrocytes 6.88
RNA sequencing of human fibroblasts after SUPT4H1 siRNA treatment 6.88
Profiling of circular RNAs in gastric cancer tissues and adjacent normal tissues 6.84
Activating PAX Gene Family Paralogs to Complement PAX5 Leukemia Driver Mutations 6.82
MicroRNA targetome analysis during HCMV infection 6.8
Sequencing of matched pair samples (diagnosis and relapse) in human B-cell acute lymphoblastic leukemia cells (ALL) 6.76
Identification of Resistance Genes to BRAF Inhibitor in Melanoma by piggyBac Transposon Activation Mutagenesis Screen 6.74
MEK inhibition rewires enhancer landscapes in RAS-driven Rhabdomyosarcoma to unlock a myogenic differentation block 6.7
Epigenetic Reprogramming of mutant RAS-driven Rhabdomyosarcoma via MEK Inhibition 6.7
HNF1 regulates critical functions of the human epididymis epithelium. 6.65
HNF1 regulates critical functions of the human epididymis epithelium. [RNA-Seq] 6.65
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation [RNA_Chondroblastoma_H3K36M_H3WT] 6.64
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation 6.64
GLIS3 Transcriptionally Activates WNT Genes to Promote Differentiation of Human Embryonic Stem Cells to Posterior Neural Progenitors 6.63
Impact of HypERrlnc Knockdown on the human pericyte transcriptome 6.63
Regulation of PRMT5-MDM4 axis is critical in the response to CDK4/6 inhibitors in melanoma 6.59
Estrogen receptor and mTOR signaling rewires cancer metabolism in obesity-associated breast cancer 6.58
Toxoplasma gondii infection of human retinal pigment epithelial cells 6.55
Regionally distinct astrocyte interferon signaling promotes blood-brain barrier integrity and limits immunopathology during neurotropic viral infection 6.54
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming 6.51
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming (RNA-seq fibroblasts) 6.51
Analysis of Combined Transcriptomes Identifies Gene Modules Differentially Responding to Pathogenic Stimulation in Vascular Smooth Muscle and Endothelial Cells 6.51
DNA damage signaling mediates the functional antagonism between replicative senescence and terminal muscle differentiation 6.43
The landscape of alternative splicing in aggressive prostate cancers 6.41
FUS mutant human motoneurons transcriptome analysis reveals altered pathways and impairment of microRNA function 6.37
Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance [RNA-seq] 6.34
Maturation of human iNSCs 6.33
Global loss of epigenetic and transcriptional fidility defines a subclass of cancer with immunotherapy resistance 6.26
Genome-wide analysis of YAP and TFCP2 down-regulated genes in liver cancer cells 6.25
Genome-wide analysis of YAP and TFCP2 occupancy and regulated expression in liver cancer cells 6.25
Transcriptome variation among human embryonic stem cell lines impacts on their differentiation 6.21
Synectin Promotes Fibrogenesis by Regulating PDGFR Isoforms Through Distinct Mechanisms 6.17
The Role of Histone H3 Lysine 36 Methylation in Reprogramming of fibroblasts and on Induced Pluripotent stem Cell Generation 6.17
Induction of human hemogenesis in adult fibroblasts by defined factors and hematopoietic co-culture 6.16
A rare subpopulation of melanoma cells with low expression of metastasis suppressor NME1 has a neural crest-like phenotype and is highly metastatic in vivo 6.16
Capturing the biology of mild versus severe disease in a pluripotent stem cell-based model of Familial Dysautonomia 6.13
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition. 6.13
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition [RNA-Seq] 6.13
WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription 6.13
RNA sequencing for human induced pluripotent stem cell cardiomyocyte differentiation 6.11
Global Regulation of Alternative Internal Exon Usage by mRNA 3' End Formation Factors [RNA-Seq] 6.08
Global Promotion of Alternative Internal Exon Usage by mRNA 3' End Formation Factors 6.08
Expression profile of GIST48 cells with siETV1 or siFOXF1 knockdown 6.02
FOXF1 defines the core-regulatory circuitry in gastrointestinal stromal tumor (GIST) 6.02
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition 6.01
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition [RNA-Seq] 6.01
Single cell transcriptome of peritoneal cells 6.0
AUF-1 affected genes in human skin cells 5.99
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations [RNA-seq] 5.9
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations 5.9
MYT1 attenuates neuroblastoma cell differentiation by inhibiting retinoic acid signaling pathway 5.9
Human pluripotent stem cell-derived brain tumor model uncovered embryonic stem cell signature as a key driver in atypical teratoid/rhabdoid tumor (RNA-Seq) 5.9
Transcriptome analysis of PRMT6 knock-out in NT2/D1 cells 5.89
Genomic location of PRMT6-dependent H3R2 methylation is decisive for the transcriptional outcome of associated genes 5.89
The impact of stanniocalcin 1 on the transcriptome of human cord blood stem/progenitors 5.88
Global gene expression profile of dasatinib-resistant RCH-ACV cells 5.86
Bone marrow-derived and dental pulp-derived human mesenchymal stem cell RNA-Seq 5.83
mRNA expression data from human parthenogenetic haploid ESCs (hPGES), normal ESCs (H9) and human fibroblast 5.82
Genomic analysis of human parthenogenetic haploid ESCs (hPGES), normal human ESCs(H9) and human forskin fibroblast 5.82
RNA-seq of young and quiescent MRC-5 human fibroblasts 5.82
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders [lnc-Nr2f1 overexpression] 5.8
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders 5.8
Primary human trophoblast from term placenta 5.8
Identification of PAX7-induced transcriptional changes and PAX7 genomic binding during skeletal myogenic differentiation of H9 embryonic stem cells 5.79
RNA Sequencing Analysis of villus tissues from unexplained recurrent spontaneous abortion patients and controls with induced abortions 5.78
Transcriptional effect of ETV1 knockdown in melanoma cells 5.7
Maturing an Enteric Nervous System in Human Intestinal Organoid-derived Tissue-Engineered Small Intestine 5.7
4sUDRB-seq: measuring transcription elongation and initiation genomewide 5.7
Expression profiling by high throughput sequencing of tumors derived from human prostate epithelial cells transformed with the oncogenes N-Myc and myrAKT1. 5.7
RNA-seq of tumor cells following angiopellosis extravasation 5.68
Enriched retinal ganglion cells derived from human embryonic stem cells (RNA-seq) 5.68
Human induced pluripotent stem cell-derived vocal fold mucosa mimics development and responses to smoke exposure 5.67
Functional interactions between Mi-2β and AP1 complexes control response and recovery from barrier disruption 5.66
Gene expression activation in CLL mediated by MSCs contact 5.62
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis 5.62
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis [bulk RNA-Seq] 5.62
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure by siRNA knockdown of Anillin [tpo8] 5.59
Identification of a dynamic core transcriptional network in t(8;21) AML regulating differentiation block and self-renewal [RNA-Seq] 5.59
Identification of a dynamic core transcriptional network in t(8;21) AML regulating differentiation block and self-renewal 5.59
Identifying ASCL1 target genes in primary GBM stem cell cultures [RNA-seq] 5.58
DUX4-induced dsRNA and MYC mRNA Stabilization Activate Apoptotic Pathways in Human Cell Models of Facioscapulohumeral Dystrophy 5.58
Transcriptomic alterations in fibroblasts from Parkinson's disease patients carrying Parkin mutations 5.42
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma 5.4
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma [RNA-seq] 5.4
IL-6 augments IL-4-induced polarization of primary human macrophages through synergy of STAT3, STAT6 and BATF transcription factors 5.39
Effect of mitochondria deficiency on senescence-associated gene expression 5.29
RNAseq of Extracellular vesicle RNAs and cellular RNAs from HPASMCs with or without TGF-b1 or BMP4 treatment 5.29
Race-specific transcriptome and Long non-coding RNA of ADT-resistant African-American prostate cancer cell models. 5.27
Characterization of macrophage - cancer cell crosstalk in estrogen receptor positive and triple-negative breast cancer 5.25
Human RELA haploinsufficiency results in autosomal dominant chronic mucocutaneous ulceration: the transcriptional profile of RelA haploinsufficient patients 5.23
Transcriptome of iPSC-derived Cerebral Organoids with Heterozygous Knockout in CHD8 5.21
Single Cell Analysis Reveals Unexpected Transcriptional Heterogeneity of Neural Progenitors in the Developing Human Cortex 5.21
PAX3-FOXO1 requires BRD4 to drive oncogene addiction in RMS cells [RNA-seq] 5.19
Epigenetic Lanscape and BRD4 Transcriptional Dependency of PAX3-FOXO1 Driven Rhabdomyosarcoma 5.19
Apoptosis enhancing drugs overcome innate platinum resistance in CA125 negative tumor initiating populations of high grade serous ovarian cancer 5.17
High-Throughput Kinetic Analysis of Fractional Killing 5.14
Gene expression analysis in U251 and U87 cells transduced with NANEP5 vector. 5.11
JQ1 +/- Vemurafenib in BRAF mutant melanoma (A375) 5.11
Next Generation Sequencing Facilitates Quantitative Analysis of human patient derived primary Glioblastoma (GBM) cancer cell Transcriptomes 5.07
SETBP1-WT and SETBP1-G870S transcriptional profiles [RNA-Seq] 5.06
SETBP1-WT and SETBP1-G870S epigenetic landscapes 5.06
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation (RNA-Seq) 5.05
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation 5.05
Metformin induces chromosome reorganization and changes in gene expression in normal human fibroblasts 5.01
Transcriptome profiling of de-differentiated chondrocytes over-expressing miR-138 or miR-181ab1 during osteogenic induction 5.0
Combinatorial Reprogramming of Estrogen Signaling by the Nuclear Receptor Family 3C 4.98
Transcriptome profiling of 5 human adenocarcinoma cell lines 4.9
Ribosome Incorporation into Somatic Cells Promotes Lineage Transdifferentiation towards Multipotency 4.88
Ribosome Incorporation into Somatic Cells Promotes Lineage Transdifferentiation towards Multipotency [RNA-Seq] 4.88
Inhibition of Enhancer of Zeste Homologue 2 attenuates TGF-β dependent hepatic stellate cell activation and liver fibrosis 4.87
Total RNA sequencing of APC mutant and wt colonic organoids 4.85
RNA-Seq analysis of neurons derived from induced pluripotent stem cells reprogrammed from dental pulp 4.84
RNA sequencing of ESC/iPSC-derived purified PAX6-GFP neural progenitors form control and Phelan-Mcdermid patients 4.82
Analyzing the interactions of mRNAs, miRNAs, lncRNAs and circRNAs to predict competing endogenous RNA networks in glioblastoma 4.81
microRNA-seq and RNA-seq reveals changes in the astrocyte transcriptome following Borrelia burgdorferi infection 4.8
RNA-seq reveals changes in the astrocyte transcriptome following Borrelia burgdorferi infection 4.8
Human iPSC-derived glomeruli provide an advanced model to interrogate podocyte biology and accurately recapitulate podocytopathy 4.77
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray [RNA-Seq] 4.71
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray 4.71
Identification of PRMT5-dependent genes in ESA+CD24lowCD44+ MCF7 cells 4.69
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. [RNA-seq] 4.64
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. 4.64
Obstructed defecation – an enteric neuropathy? An exploratory study of patient samples 4.64
Expression profiles of the four human major ectodermal lineages 4.63
Splicing and gene expression changes in human MDAM-MB231 breast cancer cells with TRA2B knockdown 4.62
RNA-seq of Human neck of femur (NOF) fracture hip and osteoarthritic (OA) cartilage 4.61
Long noncoding RNA ROCR contributes to SOX9 expression and chondrogenic differentiation of human mesenchymal stem cells 4.61
Identification of elevated A-to-I editing sites due to expression of an active ADAR3 mutant in human glioblastoma cells 4.45
RNA-seq analysis of breast cancer 4.34
RNA-seq analysis and shRNA screen of breast cancer 4.34
Identification of a LIF-responsive replication-competent human β cell 4.33
Transcriptome analysis of human lung epithelial cells 4.31
Endothelial Cells Control Pancreatic Cell Fate at Defined Stages through EGFL7 Signaling 4.31
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export 4.29
Transcriptomic and Epigenomic analysis of Huntington's disease and control patient iPSC-derived neural cells 4.27
mRNAseq of Huntington's disease and control patient iPSC-derived neural cells 4.27
Subtle asymmetry of gene expression in embryonic and foetal human brains 4.27
Identification of a Cell-of-Origin for Fibroblasts Comprising the Fibrotic Reticulum in Idiopathic Pulmonary Fibrosis 4.25
mRNA differential expression analysis in a human ex vivo model of chronic wounds 4.25
RNA-seq analysis of hPSC-derived brain pericyte-like cells, hPSC-derived neural crest stem cells, and primary human brain pericytes 4.24
Differentially Expressed Genes for Atrial Fibrillation Identified using RNA Sequencing from Paired Human Left and Right Atrial Appendages. 4.19
Next Generation Sequencing Facilitates Quantitative Analysis of UVB(20mJ/cm2 and 40mJ/cm2) exposed and untreated HaCaT keratinocytes Transcriptomes 4.16
UTX and 53BP1 co-regulate genetic programs for neural differentiation of human embryonic stem cells 4.15
UTX and 53BP1 co-regulate genetic programs for neural differentiation of human embryonic stem cells [RNA-seq] 4.15
Gene expression analysis of breast cancer cell-lines 4.14
Gene expression and genome-wide location analysis of breast cancer cell-lines 4.14
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [RNA-Seq III] 4.11
FGF2 regulation of gene expression in stable inducible Neurons 4.1
Transcriptome analysis reveals determinant stages controlling human embryonic stem cell commitment to neuronal cells 4.03
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HOM] 3.99
Next Generation Sequencing Compares Effects of microRNA-9 perturbation in control and SZ hiPSC NPCs 3.86
SMN deficiency in spinal muscular atrophy causes widespread intron retention and DNA damage 3.85
Post-transcriptional remodelling is temporally deregulated during motor neurogenesis in human ALS models 3.83
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability 3.79
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (22RV1 RNA-seq) 3.79
Gene expression of thyroid cancer cell lines 3.77
AML subtype is a major determinant of the association between prognostic gene expression signatures and their clinical significance. 3.76
GATA3 enhances the neurogenic potential of primary human astrocytes after traumatic injury [exp2] 3.75
Generation, transcriptome profiling, and functional validation of cone-enriched human retinal organoids 3.75
RNA-seq of MCF10A cells and CAF 3.7
Transcriptome of iPSC-derived Neural Cells with Heterozygous Knockout in CHD8 3.67
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation II 3.66
PT2385 HIF2A inhibitor treatment of patient derived orthotopic xenograft neuroblastoma cells in the presence or absence of hypoxia 3.66
Molecular Pathology of adverse local tissue reaction caused by metal-on-metal implants 3.61
KMT2C medaites the estrogen dependence of breast cancer through regulation of ERα enhancer function 3.59
A practical evaluation of alignment algorithms for RNA variant calling analysis 3.59
Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration 3.58
Identifying markers predicting successful graft outcome for clinical translation of hESC-based cell therapy for Parkinson’s disease 3.56
Cerebral Organoids Recapitulate Epigenomic Signatures of the Human Fetal Brain 3.55
Engineering Patient-Specific Tissue Implants 3.55
Transcriptome of U251 cells overexpression complement component 7 3.48
Hyper-activation of HUSH complex function by Charcot-Marie-Tooth disease mutation in MORC2 3.45
Patient-derived xenograft models of non-small cell lung cancer for evaluating targeted drug sensitivity and resistance 3.42
Splicing and gene expression changes in human mammary epithelial MCF-10A cells expressing SR or SR-like proteins 3.42
LMO1 Synergizes with MYCN to Promotes Neuroblastoma Initiation and Metastasis 3.36
Endothelial-AGO1-knockout (EC-AGO1-KO) mice and wild-type (WT) littermates 3.35
RNA Seq of HMVEC under hypoxia 3.35
Paxillin regulates genomic networks in prostate cancer [PC3] 3.32
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of human mesenchymal stem cells differentiation from human embryonic stem cells and adult bone marrow mesenchymal stem cells 3.29
Morphological and molecular characterization of human dermal lymphatic collectors 3.26
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 3.26
RNA sequencing reveals levamisole target genes PTPRZ1 and MDK and their links to interferon pathway in human podocytes 3.23
Transcriptomic analysis to underly the heterogeneity between 4 cellular models derived from patients diagnosed with pediatric high-grade gliomas under controlled atmosphere (modulation of oxygen level). 3.22
Effect of Polybrominated diphenyl ethers (PBDEs) on gene expression of MCF7 cells 3.18
Immunophenotyping and Transcriptomic Outcomes in PDX-Derived TNBC Tissue 3.12
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma [RNA-seq] 3.11
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma 3.11
Transcriptome analysis of PC9 cells with gefitinib or/and hypoxia treatment and comparison with gefitinib resistant PC9 cells and ALDH positive PC9 cells 3.11
Conservative alteration of chromosomal expression pattern across human solid tumor types 3.04
Gene expression profiling associated with knockdown of LKB1 in human intrahepatic cholangiocarcinoma 2.99
RNA deep sequencing to compare genome-wide differences between PRMT5/knockdown and control AML cells 2.9
SOX21 ensures rostral forebrain identity by suppression of WNT8B during neural regionalization of human embryonic stem cells 2.87
RNAseq analysis of ruxolitinib treated breast cancers 2.85
Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression 2.81
Histone Demethylases KDM3A and KDM4C regulate mesenchymal stromal cell senescence and bone aging through condensin-mediated heterochromatin organization 2.75
Transcriptome Analysis and Functional Identification of Adipose-Derived Mesenchymal Stem Cells in Secondary Lymphedema 2.74
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes 2.74
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes [RNA-Seq] 2.74
H3.3K27M cooperates with p53 loss and Pdgfra gain in mouse embryonic neural progenitor cells to induce invasive high-grade gliomas [Human RNA-Seq] 2.72
H3.3K27M cooperates with p53 loss and Pdgfra gain in mouse embryonic neural progenitor cells to induce invasive high-grade gliomas 2.72
Epigenetic siRNA and chemical screens identify SETD8 inhibition as a new therapeutic strategy of p53 reactivation in high-risk Neuroblastoma. 2.7
Transcriptomics analysis of gene expression in normal and METTL3 or WTAP deficient Human HeLa cells 2.63
Bi-allelic Alteration and Dysregulation of the Hippo Pathway in Mucinous Tubular and Spindle Cell Carcinoma of the Kidney 2.62
Altered mRNA splicing by mutant p53 activates oncogenic RAS in pancreatic cancer 2.61
RNAseq data from Mesenchymal stem cells treated with TCDD or 1-methyl tryptophan 2.6
Effects of transcription on genome - nuclear lamina interactions: RNA-seq data 2.6
Effects of transcription on genome - nuclear lamina interactions 2.6
Comprehensive analysis of microRNA expression in regionalized human neural progenitor cells reveals microRNA-10 as a caudalizing factor 2.59
Transcriptome analysis of SH-SY5Y cells after knockdown of circSLC45A4 2.57
RNA-seq analysis of gene expression patterns during hESC neural differentiation 2.57
hESC neural differentiation 2.57
Epigenetic Control of Skeletal Development by the Histone Methyltransferase Ezh2 2.56
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans [human scRNA-seq] 2.56
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans 2.56
RNA-Seq expression profiling of hepatocellular carcinoma and adjacent non-tumor liver tissues 2.55
Folate modulation induces chromosomal instability and higher proliferation of immortalized human keratinocytes 2.55
Oncogenic changes and EMT in normal human bile duct epithelial cells are caused by parasite-derived materials and N-nitrosodimethylamine 2.5
Reprogramming of human stem cells towards a rejuvenated and transformation-resisting state by recoding a single nucleotide 2.5
RNA-Seq comparative analysis of human neuroblastoma cells before and after their confrontation to the embryonic microenvironment 2.48
BMS-470539 on human synovial fibroblasts 2.46
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML [RNA-Seq human] 2.42
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML 2.42
GATA3 enhances the neurogenic potential of primary human astrocytes after traumatic injury [exp1] 2.35
An acquired vulnerability of drug resistant melanoma with therapeutic potential 2.31
RNA Seq data: A375, A375R, A375DR vorinostat treated, and biopy samples from patients pre- and post- treated with Vorinostat 2.31
Reconstitution of the human pancreatic niche stimulates differentiation of hESCs into beta cells and reveals new signals for pancreatic endocrine cell maturation 2.28
Aortic Valve Tissue: Stenosis vs. Sclerosis 2.25
Investigate A2M treatment on human prostate cancer and mouse liver 2.23
Investigate A2M treatment on human prostate cancer xenograft in mice 2.23
Genome-Wide DNA Methylation Encodes Cardiac Transcriptional Reprogramming in Human Ischemic Heart Failure [DNA Methylation] 2.22
Genome-Wide DNA Methylation Encodes Cardiac Transcriptional Reprogramming in Human Ischemic Heart Failure [RNA-Seq] 2.22
Expression charcaterization of an internal protocol developed to differentiate RPE cells 2.19
Pain-driven transcriptome changes in synovium of knee osteoarthritis patients 2.18
PLZF targets developmental enhancers for activation during osteogenic differentiation of human mesenchymal stem cells 2.16
PLZF targets developmental enhancers for activation during osteogenic differentiation of human mesenchymal stem cells (RNA-seq) 2.16
Widespread Transcription beyond mRNA 3’ Ends Yields Abundant Regulatory RNAs 2.14
RNA-seq analysis of the role of HBO1 (KAT7/MYST2) in the ovarian cancer cell line UWB1.289. 2.14
Robust generation of honemogeneous midbrain organoids with in vivo–like cellular composition facilitates neurotoxin-based Parkinson’s disease modeling 2.12
Gene expression regulated by CSA and CSB in neuroblastoma cell line 2.07
Aging signatures developed from a longitudinal study design are dominated by reduced transcription of genes involved in protein synthesis. 1.96
RNA-seq from primary skin fibroblasts, derived of matched pairs of middle and late donor age 1.96
Global transcriptome analysis in the MYCN-amplified neuroblastoma cell line IMR5-75 upon inducible MYCN-knockdown 1.94
Effects of plasticizers (bisphenol A, bisphenol AF) and an herbicide in MCF7 human breast cancer cells 1.93
RNA sequencing of Asthmatic Human Airway Smooth Muscle Cells I 1.91
The Wnt/β-catenin-signaling pathway is modulated by androgen ablation therapy for advanced clinical prostate cancer and contributes to androgen independent cell growth 1.9
Epigenetic activation and memory at a TGFB2 enhancer in systemic sclerosis 1.88
PSEN1ΔE9, APPswe and APOE4 confer disparate phenotypes in human iPSC-derived microglia 1.87
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer 1.85
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer [RNA-Seq] 1.85
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas [RNA-Seq] 1.84
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas 1.84
RNA-sequencing of human tendon after injury 1.81
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [H1 RNA-seq] 1.81
Dissecting neural differentiation regulatory networks through epigenetic footprinting 1.8
Transcriptome profiling of omental adipose tissues in human obesity by RNA-Seq 1.79
Defective removal of ribonucleotides from DNA promotes systemic autoimmunity 1.76
Dynamic developmental signaling logic underlying lineage bifurcations during human endoderm induction and patterning from pluripotent stem cells [Endoderm RNA-seq and ChIP-seq data sets] 1.71
Dynamic developmental signaling logic underlying lineage bifurcations during human endoderm induction and patterning from pluripotent stem cells 1.71
Transcriptional profiling at the DLK1/MEG3 domain explains clinical overlap between imprinting disorders 1.68
The chromatin modifier CHD8 targets autism risk genes during human neurodevelopment  1.68
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence [RNA-Seq] 1.68
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence 1.68
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures [RNA-Seq] 1.66
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures 1.66
RNA-seq of ASXL2 shRNA KD in SKNO-1 cells 1.64
Vammin induces a highly efficient angiogenic response through VEGFR-2/NRP-1 and bypasses the regulatory function of VEGFR-1 1.57
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation 1.52
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation [RNA-Seq] 1.52
mRNA Sequencing of Human PromoCells Using Random Primed mRNA-Sequencing Technique 1.51
Transcriptomic analysis to functionally map the intrinsically disordered domain of EWS/FLI [Experiment 1] 1.5
Identification of differentially expressed circRNA in gallbladder cancer compared with matched normal tissue 1.46
Genomic profiling of biliary tract cancer cell lines reveals molecular subtypes and actionable drug targets 1.42
RNA-seq of SCLC PDX models treated with EP 1.42
Role of SUMOylation in differential ERα transcriptional repression by SERMs and pure antiestrogens in breast cancer cells 1.41
Deep sequencing of transcript levels in pluripotent stem cells and their differentiated derivatives in all three germ layers 1.34
BI Human Reference Epigenome Mapping Project 1.33
Aneuploidy-induced cellular stresses limit autophagic degradation. 1.32
Molecular Biomarkers Screened by Next-generation RNA Sequencing for non-sentinel lymph node status predicting in breast cancer patients with metastatic sentinel lymph node 1.32
RNA-Seq of Kaposi’s sarcoma reveal alterations in glucose and lipid metabolism 1.32
Vitamin d receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy 1.31
Evaluation of the effectiveness of semen collection and sperm purification methods for spermatozoa transcript profiling 1.3
Zika Virus Has Oncolytic Activity against Glioblastoma Stem Cells 1.3
Epigenome regulation during epidermal lineage commitment 1.25
CLIC5: a novel ETV6 target gene in childhood acute lymphoblastic leukemia 1.24
Epigenetic alterations affecting transcription factors and signaling pathways in stromal cells of endometriosis 1.22
Epigenetic alterations affecting transcription factors and signaling pathways in stromal cells of endometriosis: Expression data (RNA-seq) 1.22
Replicative senescence is associated with nuclear reorganization and DNA methylation at specific transcription factor binding sites 1.17
Replicative senescence is associated with nuclear reorganization and DNA methylation at specific transcription factor binding sites (RNA-seq) 1.17
Genome-wide maps of transcriptomic and epigenomic state in melanoma cell lines 1.14
Concomitant BCORL1 and BRAF mutations in vemurafenib-resistant melanoma cells 1.14
Downregulation of DDX5/DDX17 and REST 1.06
RNA-seq in endometrial stromal tumors 1.05
Transcriptional regulation in pluripotent stem cells by Methyl CpG binding protein 2 (MeCP2) 1.03
Profiling premalignant lesions in lung squamous cell carcinomas identifies mechanisms involved in stepwise carcinogenesis 1.01
Prostaglandin E2 inhibits pro-fibrotic function of human pulmonary fibroblasts by disrupting Ca2+-signaling 0.99
mRNA-sequencing of breast cancer subtypes and normal tissue 0.93
Identification and validation of differentially expressed transcripts by RNA-Sequencing of formalin-fixed, paraffin-embedded (FFPE) lung tissue from patients with Idiopathic Pulmonary Fibrosis 0.92
Genome-wide DNA hypomethylation and RNA:DNA hybrid accumulation in Aicardi-Goutières syndrome 0.88
circ-ZNF609 regulates G1-S progression in Rhabdomyosarcoma 0.87
Next Generation Sequencing Facilitates Comparisons of Control and Schizophrenia-Patient derived hiPSC-derived neurons 0.87
The global transcriptome analysis in the time course of hESC-derived cardiac differentiation 0.85
Group A Streptococcus M1T1 Intracellular Infection of Primary Tonsil Epithelial Cells Dampens Levels of Secreted IL-8 Through the Action of SpyCEP 0.84
iPSC-Derived Cholangiocytes 0.84
FOXO1 is an oncogenic mediator in AML1-ETO leukemia 0.83
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD) 0.81
Gene expression profiles of active and restricted R/G-HIV+ primary human fetal astrocytes 0.79
Characterization of parental and rociletinib-resistant derived H1975 cell lines 0.76
TGFβ1-mediated functional inhibition of mesenchymal stromal cells in MDS and AML 0.7
Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma 0.69
CUREfast: Accelerating research with families 0.69
RNA-Seq analysis of proliferating 4N and 2N RPE1 cells derived from single cell clones following inhibition of Aurora B to induce polyploidization [tpo10] 0.68
Neutrophils RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 0.62
Epigenome regulation during epidermal lineage commitment [RNA-seq] 0.6
Molecular analysis of renal cell carcinoma with unclassfied histology 0.58
Molecular analysis of renal cell carcinoma with unclassfied histology [gene expression] 0.58
Genome wide impact of loss of mechanoluminal stimulation on neonatal intestine 0.55
Illumina HiSeq Sequencing on Breast cancer PDX samples 0.5
mRNAseq of Huntington's disease and control patient iPSC-derived brain microvascular endothelial cells 0.46
Propargite, an environmental chemical, interacts with GWAS identified diabetes genes to impact human pancreatic β-cell death 0.45
HDAC and NFκB antagonists synergistically inhibit growth and metastatic dissemination of MYC-driven medulloblastoma 0.42
Transcriptomic analysis of human macrophages in 3D 0.42
YAP and MRTF-A, transcriptional co-activators of RhoA- mediated gene expression, are critical for glioblastoma tumorigenicity 0.38
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [BAV] 0.36
Anaylsis of the effect of down-regulation of the EWS-FLI1 fusion protein in Ewing Sarcoma cells by RNA-seq. 0.33
Comparative analysis of WT and ZEB1 KO cells in different stages during differentiation 0.33
The acetyllysine reader BRD3R promotes human nuclear reprogramming and regulates mitosis 0.23
To identify transcripts that are differentially expressed in the MYCN amplified vs MYCN non-amplified cell lines using Next Generation Sequencing 0.21
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. 0.2
Identification of downstream genes regulated by YAP1 through knockdown and overexpression of YAP1 in U251 cell with a stably expression of mutant APP 0.18
Generation of low passage high grade serous ovarian cancer cell lines from primary tumors 0.17
Impaired DNA damage metabolism promotes autoimmunity in TREX1 deficiency  0.15
Next generation sequencing of advanced non-castrate prostate cancer treated with docetaxel chemotherapy 0.14
Measure transcript integrity using RNA-seq data 0.13
RNA sequencing of lesional and nonlesional skin from patients with atopic dermatitis 0.11
RNA sequencing and pathway analysis identify important pathways involved in hypertrichosis and intellectual disability in patients with Wiedemann-Steiner syndrome 0.09
Integration of genome-wide DNA methylome and transcriptome of human intestinal fibroblasts reveals novel candidate gene signatures in Crohn’s disease-associated fibrosis 0.09
Random mono-allelic expression in MECP2-mutated cells 0.08
RNA sequencing of hiPSC derived neural crest populations from Familial Dysautonomia patients 0.06
Transcriptional profiling of growing and senescent WT and IL-1R-depleted IMR90 cells 0.03
Preliminary Report of Transplantation of Human Fetal Retinal Pigment Epithelial Cells on Age-related Macular Degeneration Patients 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation